1.5-Tesla Multiparametric-Magnetic Resonance Imaging for the detection of clinically significant prostate cancer

Authors

  • Cristian Popita
  • Anca Raluca Popita
  • Adela Sitar-Taut
  • Bogdan Petrut
  • Bogdan Fetica
  • Ioan Coman

DOI:

https://doi.org/10.15386/cjmed-690

Keywords:

Prostate cancer, Multiparametric-MRI, Cancer imaging, 1.5-T MRI

Abstract

Background and aims. Multiparametric-magnetic resonance imaging (mp-MRI) is the main imaging modality used for prostate cancer detection. The aim of this study is to evaluate the diagnostic performance of mp-MRI at 1.5-Tesla (1.5-T) for the detection of clinically significant prostate cancer.

Methods. In this ethical board approved prospective study, 39 patients with suspected prostate cancer were included. Patients with a history of positive prostate biopsy and patients treated for prostate cancer were excluded. All patients were examined at 1.5-T MRI, before standard transrectal ultrasonography–guided biopsy.

Results. The overall sensitivity, specificity, positive predictive value and negative predictive value for mp-MRI were 100%, 73.68%, 80% and 100%, respectively.

Conclusion. Our results showed that 1.5 T mp-MRI has a high sensitivity for detection of clinically significant prostate cancer and high negative predictive value in order to rule out significant disease.

Author Biographies

Cristian Popita, The Oncology Institute “Prof. Dr. Ion Chiricuţă”, Cluj-Napoca, Romania, “Iuliu Haţieganu” University of Medicine and Pharmacy, Cluj-Napoca, Romania

Radiology and Medical Imaging

Anca Raluca Popita, Department of Radiology and Medical Imaging, The Oncology Institute “Prof. Dr. Ion Chiricuţă”, Cluj-Napoca, Romania “Iuliu Haţieganu” University of Medicine and Pharmacy, Cluj-Napoca, Romania

Radiology and Medical Imaging

Adela Sitar-Taut, New Blue Life Medical Center, Cluj-Napoca, Romania

Internal Medicine

Bogdan Petrut, Department of Urology, The Oncology Institute “Prof. Dr. Ion Chiricuţă”, Cluj-Napoca, Romania, “Iuliu Haţieganu” University of Medicine and Pharmacy, Cluj-Napoca, Romania

Urology

Bogdan Fetica, Department of Pathology, The Oncology Institute “Prof. Dr. Ion Chiricuţă”, Cluj-Napoca, Romania

Pathology

Ioan Coman, Department of Urology, Clinical Municipal Hospital, Cluj-Napoca, Romania, “Iuliu Haţieganu” University of Medicine and Pharmacy, Cluj-Napoca, Romania

Urology

Downloads

Additional Files

Published

2017-01-30

How to Cite

1.
Popita C, Popita AR, Sitar-Taut A, Petrut B, Fetica B, Coman I. 1.5-Tesla Multiparametric-Magnetic Resonance Imaging for the detection of clinically significant prostate cancer. Med Pharm Rep [Internet]. 2017 Jan. 30 [cited 2025 Oct. 5];90(1):40-8. Available from: https://medpharmareports.com/index.php/mpr/article/view/690

Issue

Vol. 90 No. 1 (2017)

Section

Original Research

License

The authors are required to transfer the copyright of the published paper to the journal. This is done by agreeing to sign the Copyright Assignment Form. Whenever the case, authors are also required to send permissions to reproduce material (such as illustrations) from the copyright holder.

 Creative Commons License
The papers published in the journal are licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.